← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 29, 2019Last known activity
Jan 18, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Recent trials (9)
- NCT06210126Sponsor investigatorN/AJan 18, 2024
- NCT06210126Lead sponsorN/AJan 18, 2024
- NCT05542797Lead sponsorPhase 4Oct 31, 2022
- NCT05542797Reponsible party - principal investigatorPhase 4Oct 31, 2022
- NCT05520021Lead sponsorN/ASep 1, 2022
- NCT05520021Reponsible party - principal investigatorN/ASep 1, 2022
- NCT04112394Sponsor investigatorN/ASep 29, 2019
- NCT04112394Reponsible party - principal investigatorN/ASep 29, 2019
- NCT04112394Lead sponsorN/ASep 29, 2019
Details
- Last known activity
- Jan 18, 2024